Vienna, 3 - 5 November 2025

BioEurope – Vienna

Meet InnoCore Pharmaceuticals at BioEurope 2025 – Advance Your API into a Long-Acting Injectable

InnoCore Pharmaceuticals is excited to attend BioEurope 2025, where you can connect with our team to explore our cutting-edge solutions to advance your API into a long-acting injectable.

Vincent de Boer, Business Development Manager, and Martin Bakker, Chief Business Officer, will be on site to discuss how our SynBiosys® polymer platform enables the development of biodegradable long-acting injectables—without the typical limitations of aggregation, acylation, or high local pH.

Next-Generation injectables with Synbiosys

Whether you’re aiming to reduce dosing frequency or transition from IV to subQ administration, our technology offers tailored, tunable release profiles for peptides, proteins, and other biologics.

Why partner with InnoCore Pharmaceuticals?

• Extensive expertise in sustained-release formulations

• Proven track record in developing bespoke long-acting injectable formulations for peptides, proteins, and other biologics

• Tunable SynBiosys® polymer platform to develop formulations with 1 week or several months sustained release systems; dependable on your needs

• Strong collaborative approach from early-stage development through to clinical supply

Arrange a meeting during the BioEurope!

We would love to discuss how our drug delivery technologies can support your development goals. You can connect with Martin or Vincent through the BioEurope partnering platform, reach out to us directly via the contact form below, or contact us on: +31 50 575 3100

"*" indicates required fields